Genome-wide CRISPR knockouts (Chronos) across 1,100+ cancer cell lines plus drug sensitivity panels — foundational resource for target validation.
Details
- version
- 24Q4
- license
- CC-BY-4.0
- domain
- neurodegeneration
- n_rows
- 1100
- file_format
- csv
- download_url
- https://depmap.org/portal/data_page/
- landing_page
- https://depmap.org/